# Honeywell International Inc: financial statements, quarterly

HON · Nasdaq · CIK 773840 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hon.md) · [Financials](/companies/hon/financials.md) · [Filings](/companies/hon/filings.md) · [Insiders](/companies/hon/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hon/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [5.8 d](/filings/0000773840-26-000013.md) | [8.2](/filings/0000773840-26-000013.md) | [8.6](/filings/0000773840-26-000013.md) | [8.8](/filings/0000773840-26-000013.md) | [9.2](/filings/0000773840-26-000013.md) | [8.9](/filings/0000773840-26-000057.md) | [9.3](/filings/0000773840-26-000124.md) | [4.9](/filings/0000773840-26-000143.md) | [9.8](/filings/0000773840-26-000013.md) | [9.1](/filings/0000773840-26-000057.md) | [9.7](/filings/0000773840-26-000124.md) | [5.0](/filings/0000773840-26-000143.md) |
| Cost of revenue | $bn | [3.8 d](/filings/0000773840-26-000013.md) | [5.6](/filings/0000773840-25-000037.md) | [5.9](/filings/0000773840-25-000064.md) | [6.0](/filings/0000773840-25-000105.md) | [3.9 d](/filings/0000773840-26-000013.md) | [5.5](/filings/0000773840-26-000057.md) | [5.7](/filings/0000773840-26-000124.md) | [3.2](/filings/0000773840-26-000143.md) | [14.7 d](/filings/0000773840-26-000013.md) | [5.6](/filings/0000773840-26-000057.md) | [6.1](/filings/0000773840-26-000124.md) | [3.0](/filings/0000773840-26-000143.md) |
| Gross profit | $bn | not reported | [3.2](/filings/0000773840-26-000013.md) | [3.4](/filings/0000773840-26-000013.md) | [3.4](/filings/0000773840-26-000013.md) | [3.4](/filings/0000773840-26-000013.md) | [3.5](/filings/0000773840-26-000013.md) | [3.7](/filings/0000773840-26-000013.md) | [3.2](/filings/0000773840-26-000013.md) | [3.5](/filings/0000773840-26-000013.md) | not reported | not reported | not reported |
| Research and development | $bn | [0.3 d](/filings/0000773840-26-000013.md) | [0.4](/filings/0000773840-25-000037.md) | [0.4](/filings/0000773840-25-000064.md) | [0.4](/filings/0000773840-25-000105.md) | [0.3 d](/filings/0000773840-26-000013.md) | [0.4](/filings/0000773840-26-000057.md) | [0.5](/filings/0000773840-26-000124.md) | [0.3](/filings/0000773840-26-000143.md) | [1.0 d](/filings/0000773840-26-000013.md) | [0.5](/filings/0000773840-26-000057.md) | [0.5](/filings/0000773840-26-000124.md) | [0.2](/filings/0000773840-26-000143.md) |
| Selling, general and administrative | $bn | [1.1 d](/filings/0000773840-26-000013.md) | [1.3](/filings/0000773840-25-000037.md) | [1.4](/filings/0000773840-25-000064.md) | [1.4](/filings/0000773840-25-000105.md) | [1.2 d](/filings/0000773840-26-000013.md) | [1.3](/filings/0000773840-26-000057.md) | [1.4](/filings/0000773840-26-000124.md) | [1.1](/filings/0000773840-26-000143.md) | [2.1 d](/filings/0000773840-26-000013.md) | [1.3](/filings/0000773840-26-000057.md) | [1.3](/filings/0000773840-26-000124.md) | [1.0](/filings/0000773840-26-000143.md) |
| Operating income | $bn | [1.3 d](/filings/0000773840-26-000013.md) | [2.1](/filings/0000773840-25-000037.md) | [2.2](/filings/0000773840-25-000064.md) | [2.3](/filings/0000773840-25-000105.md) | [1.1 d](/filings/0000773840-26-000013.md) | [2.0](/filings/0000773840-26-000057.md) | [2.1](/filings/0000773840-26-000124.md) | [0.9](/filings/0000773840-26-000143.md) | [5.6 d](/filings/0000773840-26-000013.md) | [2.1](/filings/0000773840-26-000057.md) | [2.2](/filings/0000773840-26-000124.md) | [1.1](/filings/0000773840-26-000143.md) |
| Interest expense | $bn | not reported | not reported | not reported | not reported | not reported | [0.3](/filings/0000773840-26-000057.md) | [0.3](/filings/0000773840-26-000124.md) | [0.3](/filings/0000773840-26-000143.md) | not reported | [0.4](/filings/0000773840-26-000057.md) | [0.4](/filings/0000773840-26-000124.md) | [0.1](/filings/0000773840-26-000143.md) |
| Income tax | $bn | [0.0 d](/filings/0000773840-26-000013.md) | [0.4](/filings/0000773840-25-000037.md) | [0.4](/filings/0000773840-25-000064.md) | [0.4](/filings/0000773840-25-000105.md) | [0.0 d](/filings/0000773840-26-000013.md) | [0.4](/filings/0000773840-26-000057.md) | [0.2](/filings/0000773840-26-000124.md) | [0.2](/filings/0000773840-26-000143.md) | [0.6 d](/filings/0000773840-26-000013.md) | [0.1](/filings/0000773840-26-000057.md) | [1.6](/filings/0000773840-26-000124.md) | [0.1](/filings/0000773840-26-000143.md) |
| Net income | $bn | [1.3 d](/filings/0000773840-26-000013.md) | [1.5](/filings/0000773840-26-000013.md) | [1.5](/filings/0000773840-26-000013.md) | [1.4](/filings/0000773840-26-000013.md) | [1.3](/filings/0000773840-26-000013.md) | [1.4](/filings/0000773840-26-000057.md) | [1.6](/filings/0000773840-26-000124.md) | [1.8](/filings/0000773840-26-000143.md) | [(0.1)](/filings/0000773840-26-000013.md) | [0.8](/filings/0000773840-26-000057.md) | [5.7](/filings/0000773840-26-000124.md) | [0.7](/filings/0000773840-26-000143.md) |
| Diluted EPS | $ per share | not reported | [2.23](/filings/0000773840-26-000013.md) | [2.36](/filings/0000773840-26-000013.md) | [2.16](/filings/0000773840-26-000013.md) | [1.96](/filings/0000773840-26-000013.md) | [2.22](/filings/0000773840-26-000057.md) | [4.90](/filings/0000773840-26-000124.md) | [5.71](/filings/0000773840-26-000143.md) | [(0.18)](/filings/0000773840-26-000013.md) | [1.29](/filings/0000773840-26-000057.md) | [17.83](/filings/0000773840-26-000124.md) | [2.08](/filings/0000773840-26-000143.md) |
| Basic EPS | $ per share | not reported | [2.24](/filings/0000773840-26-000013.md) | [2.37](/filings/0000773840-26-000013.md) | [2.17](/filings/0000773840-26-000013.md) | [1.98](/filings/0000773840-26-000013.md) | [2.24](/filings/0000773840-26-000057.md) | [4.92](/filings/0000773840-26-000124.md) | [5.74](/filings/0000773840-26-000143.md) | [(0.18)](/filings/0000773840-26-000013.md) | [1.29](/filings/0000773840-26-000057.md) | [17.92](/filings/0000773840-26-000124.md) | [2.09](/filings/0000773840-26-000143.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [7.9](/filings/0000773840-25-000010.md) | [11.8](/filings/0000773840-24-000051.md) | [9.6](/filings/0000773840-24-000082.md) | [10.6](/filings/0000773840-24-000099.md) | [9.9](/filings/0000773840-26-000013.md) | [9.7](/filings/0000773840-25-000037.md) | [10.3](/filings/0000773840-25-000064.md) | [12.9](/filings/0000773840-25-000105.md) | [12.3](/filings/0000773840-26-000143.md) | [12.0](/filings/0000773840-26-000057.md) | [8.8](/filings/0000773840-26-000124.md) | [5.7](/filings/0000773840-26-000143.md) |
| Current assets | $bn | [23.5](/filings/0000773840-25-000010.md) | [27.4](/filings/0000773840-24-000051.md) | [25.4](/filings/0000773840-24-000082.md) | [28.2](/filings/0000773840-24-000099.md) | [27.9](/filings/0000773840-26-000013.md) | [27.6](/filings/0000773840-25-000037.md) | [28.0](/filings/0000773840-25-000064.md) | [30.7](/filings/0000773840-25-000105.md) | [30.4](/filings/0000773840-26-000143.md) | [30.6](/filings/0000773840-26-000057.md) | [28.1](/filings/0000773840-26-000124.md) | [14.3](/filings/0000773840-26-000143.md) |
| Total assets | $bn | [61.5](/filings/0000773840-25-000010.md) | [65.6](/filings/0000773840-24-000051.md) | [69.3](/filings/0000773840-24-000082.md) | [73.5](/filings/0000773840-24-000099.md) | [75.2](/filings/0000773840-26-000013.md) | [75.2](/filings/0000773840-25-000037.md) | [78.4](/filings/0000773840-25-000064.md) | [80.9](/filings/0000773840-25-000105.md) | [73.7](/filings/0000773840-26-000143.md) | [74.0](/filings/0000773840-26-000057.md) | [77.3](/filings/0000773840-26-000124.md) | [53.1](/filings/0000773840-26-000143.md) |
| Current liabilities | $bn | [18.5](/filings/0000773840-25-000010.md) | [16.5](/filings/0000773840-24-000051.md) | [21.0](/filings/0000773840-24-000082.md) | [19.5](/filings/0000773840-24-000099.md) | [21.3](/filings/0000773840-26-000013.md) | [22.1](/filings/0000773840-25-000037.md) | [21.6](/filings/0000773840-25-000064.md) | [22.6](/filings/0000773840-25-000105.md) | [23.4](/filings/0000773840-26-000143.md) | [22.1](/filings/0000773840-26-000057.md) | [23.2](/filings/0000773840-26-000124.md) | [14.9](/filings/0000773840-26-000143.md) |
| Long-term debt | $bn | [18.4](/filings/0000773840-24-000099.md) | [23.4](/filings/0000773840-24-000051.md) | [23.4](/filings/0000773840-24-000082.md) | [27.7](/filings/0000773840-24-000099.md) | [26.8](/filings/0000773840-25-000105.md) | [27.1](/filings/0000773840-25-000037.md) | [30.2](/filings/0000773840-25-000064.md) | [30.2](/filings/0000773840-25-000105.md) | [28.7](/filings/0000773840-26-000143.md) | [32.1](/filings/0000773840-26-000057.md) | [31.5](/filings/0000773840-26-000124.md) | [14.2](/filings/0000773840-26-000143.md) |
| Short-term borrowings | $bn | [2.1](/filings/0000773840-25-000010.md) | [1.8](/filings/0000773840-24-000051.md) | [4.5](/filings/0000773840-24-000082.md) | [3.1](/filings/0000773840-24-000099.md) | [4.3](/filings/0000773840-26-000013.md) | [5.8](/filings/0000773840-25-000037.md) | [6.3](/filings/0000773840-25-000064.md) | [6.9](/filings/0000773840-25-000105.md) | [5.9](/filings/0000773840-26-000143.md) | [4.6](/filings/0000773840-26-000057.md) | [2.5](/filings/0000773840-26-000124.md) | [2.4](/filings/0000773840-26-000143.md) |
| Shareholders' equity | $bn | [15.9](/filings/0000773840-25-000010.md) | [16.5](/filings/0000773840-24-000051.md) | [16.9](/filings/0000773840-24-000082.md) | [17.4](/filings/0000773840-24-000099.md) | [18.6](/filings/0000773840-26-000013.md) | [17.5](/filings/0000773840-25-000037.md) | [16.1](/filings/0000773840-25-000064.md) | [16.8](/filings/0000773840-25-000105.md) | [13.9](/filings/0000773840-26-000143.md) | [13.6](/filings/0000773840-26-000057.md) | [18.5](/filings/0000773840-26-000124.md) | [22.4](/filings/0000773840-26-000143.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2,955 d](/filings/0000773840-26-000013.md) | [448](/filings/0000773840-25-000037.md) | [1,371 d](/filings/0000773840-25-000064.md) | [1,997 d](/filings/0000773840-25-000105.md) | [2,281 d](/filings/0000773840-26-000013.md) | [597](/filings/0000773840-26-000057.md) | [1,319 d](/filings/0000773840-26-000124.md) | [3,288 d](/filings/0000773840-26-000143.md) | [1,204 d](/filings/0000773840-26-000013.md) | [(650)](/filings/0000773840-26-000057.md) | [1,276 d](/filings/0000773840-26-000124.md) | [117 d](/filings/0000773840-26-000143.md) |
| Capital expenditure | $m | [66.0 d](/filings/0000773840-26-000013.md) | [233](/filings/0000773840-25-000037.md) | [259 d](/filings/0000773840-25-000064.md) | [279 d](/filings/0000773840-25-000105.md) | [100 d](/filings/0000773840-26-000013.md) | [190](/filings/0000773840-26-000057.md) | [226 d](/filings/0000773840-26-000124.md) | [(41.0) d](/filings/0000773840-26-000143.md) | [611 d](/filings/0000773840-26-000013.md) | [223](/filings/0000773840-26-000057.md) | [315 d](/filings/0000773840-26-000124.md) | [(169) d](/filings/0000773840-26-000143.md) |
| Dividends paid | $m | [711 d](/filings/0000773840-26-000013.md) | [703](/filings/0000773840-25-000037.md) | [743 d](/filings/0000773840-25-000064.md) | [715 d](/filings/0000773840-25-000105.md) | [741 d](/filings/0000773840-26-000013.md) | [732](/filings/0000773840-26-000057.md) | [747 d](/filings/0000773840-26-000124.md) | [735 d](/filings/0000773840-26-000143.md) | [762 d](/filings/0000773840-26-000013.md) | [781](/filings/0000773840-26-000057.md) | [795 d](/filings/0000773840-26-000124.md) | [240 d](/filings/0000773840-26-000143.md) |
| Share repurchases | $m | [1,528 d](/filings/0000773840-26-000013.md) | [671](/filings/0000773840-25-000037.md) | [529 d](/filings/0000773840-25-000064.md) | [0.0 d](/filings/0000773840-25-000105.md) | [455 d](/filings/0000773840-26-000013.md) | [1,902](/filings/0000773840-26-000057.md) | [1,702 d](/filings/0000773840-26-000124.md) | [100 d](/filings/0000773840-26-000143.md) | [100 d](/filings/0000773840-26-000013.md) | [1,000](/filings/0000773840-26-000057.md) | [0.0 d](/filings/0000773840-26-000124.md) | [0.0 d](/filings/0000773840-26-000143.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [673](/filings/0000773840-24-000051.md) | [670](/filings/0000773840-24-000082.md) | [667](/filings/0000773840-24-000099.md) | [657](/filings/0000773840-25-000037.md) | [654](/filings/0000773840-25-000064.md) | [654](/filings/0000773840-25-000105.md) | [652](/filings/0000773840-26-000057.md) | [321](/filings/0000773840-26-000124.md) | [319](/filings/0000773840-26-000143.md) | [638](/filings/0000773840-26-000057.md) | [319](/filings/0000773840-26-000124.md) | [319](/filings/0000773840-26-000143.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 317,358,518 at 2026-09-30, from the cover of the [10-Q filed 2026-10-22](/filings/0000773840-26-000143.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.